Exelixis (EXEL) Cash from Operations (2010 - 2026)
Exelixis' (EXEL) quarterly Cash from Operations came in at 251845000.0 in Q2 2026, up 19.11% year-on-year from 211437000.0 in Q2 2025, and down 24.49% quarter-over-quarter from 333515000.0 in Q1 2026.
Exelixis (EXEL) Cash from Operations (2010 - 2026) Analysis & Trends
Exelixis' Cash from Operations history runs 17 years deep, the most recent figure standing at 251845000.0 for Q2 2026.
- On a quarterly basis, Cash from Operations rose 19.11% year-over-year to 251845000.0 in Q2 2026; TTM through Apr 2026 was 924675000.0, a 9.74% increase from a year earlier, with the FY2026 full-year figure at 884267000.0, up 26.33% from the prior year.
- Cash from Operations fell to 251845000.0 in Q2 2026 per EXEL's latest filing, from 333515000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 333515000.0 in Q1 2026 and bottomed at 10571000.0 in Q4 2023.
- The 5-year median for Cash from Operations is 119548000.0 (2024), against an average of 148942411.76.
- Across the five-year window, Cash from Operations plunged 85.66% in 2023 and jumped 2172.85% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 73694000.0 in 2022, then plunged by 85.66% to 10571000.0 in 2023, then soared by 2466.81% to 271338000.0 in 2024, then grew by 7.0% to 290322000.0 in 2025, then fell by 13.25% to 251845000.0 in 2026.
- Per Business Quant, the three latest EXEL Cash from Operations figures stand at 251845000.0 (Q2 2026), 333515000.0 (Q1 2026), and 290322000.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 251.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 251.85 Mn |
| Apr 3, 2026 | 251.85 Mn |
| Jan 2, 2026 | 333.52 Mn |
| Jan 2, 2026 | 333.52 Mn |
| Oct 3, 2025 | 290.32 Mn |
| Oct 3, 2025 | 290.32 Mn |
| Jul 4, 2025 | 48.99 Mn |
| Jul 4, 2025 | 48.99 Mn |
| Apr 4, 2025 | 211.44 Mn |
| Apr 4, 2025 | 211.44 Mn |
| Jan 3, 2025 | 240.26 Mn |
| Jan 3, 2025 | 240.26 Mn |
| Sep 27, 2024 | 271.34 Mn |
| Sep 27, 2024 | 271.34 Mn |
| Jun 28, 2024 | 119.55 Mn |
| Jun 28, 2024 | 119.55 Mn |
| Mar 29, 2024 | 68.82 Mn |
| Mar 29, 2024 | 68.82 Mn |
| Dec 29, 2023 | 10.57 Mn |
| Dec 29, 2023 | 10.57 Mn |